Toxic effects of extended glutathione depletion by buthionine sulfoximine on murine mammary carcinoma cells.
Extended depletion of glutathione to approximately equal to 5% of control in the murine mammary carcinoma cell line 66 was achieved with a concentration of 0.05 mM buthionine sulfoximine. At 24 hours, there was no evidence for cellular toxicity from the BSO treatment per se; however, by 48 hours, there was inhibition of protein and DNA synthesis and cell growth and cell kinetic data was suggestive of both a G1 and a G2 block. Glutathione depletion to this extent (i.e., 0.13 mM vs. 2.24 mM in control) did not modify the aerobic radiation response for cells in the physiological states of proliferation, quiescence, or stimulated quiescent cells. This degree of cellular toxicity may well be cell-type dependent, but the results do suggest that caution is in order if one should attempt long-term GSH depletion in vivo.
D000818:Animals; D019328:Buthionine Sulfoximine; D002460:Cell Line; D005978:Glutathione / Q000378:metabolism*; D066298:In Vitro Techniques; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000633:toxicity; D051379:Mice; D013997:Time Factors
D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D005978:Glutathione